6 trials changed in the last 30 days: 1 stopped, 3 with notable changes, 2 with minor changes only.
Withdrawn before enrolling
Sponsor's reason: The study was withdrawn before initiation. Reasons: no ethics approval obtained and anticipated roll-out of lenacapavir
University Hospital, Basel, SwitzerlandNot applicable NCT07581600 Registry history of NCT07581600 on ClinicalTrials.gov (opens the registry)
Updated
Primary endpoint(s) modified
Also in this update: Primary and study completion pushed from Jul 2026 to Nov 2026; Interventions modified
University Hospital, Basel, SwitzerlandNot applicable NCT04966299 Registry history of NCT04966299 on ClinicalTrials.gov (opens the registry)
Updated
Enrollment reopened
University Hospital, Basel, SwitzerlandNot specified NCT02573532 Registry history of NCT02573532 on ClinicalTrials.gov (opens the registry)
Updated
Primary and study completion moved earlier from Mar 1, 2028 to Mar 1, 2027
University Hospital, Basel, SwitzerlandPhase 1 NCT07444788 Registry history of NCT07444788 on ClinicalTrials.gov (opens the registry)
Updated
Trial completed
University Hospital, Basel, SwitzerlandPhase 4 NCT04447911 Registry history of NCT04447911 on ClinicalTrials.gov (opens the registry)
Updated
Primary and study completion pushed from Dec 31, 2026 to Apr 4, 2027
University Hospital, Basel, SwitzerlandNot specified NCT04000061 Registry history of NCT04000061 on ClinicalTrials.gov (opens the registry)
Updated
| First posted | Trial | Phase | Status |
|---|---|---|---|
| 2026-09-25 | NCT07840456 Safety and Efficacy of Ruxolitinib in Patients With HNSCC and High NLR Treated With… | Phase 2 | Not Yet Recruiting |
| 2026-09-18 | NCT07829081 Research on Effective Strategies After Immunotherapy for Mismatch Repair-deficient… | Recruiting |
| Early Phase 1 | 1 | |
| Phase 1 | 8 | |
| Phase 1/2 | 4 | |
| Phase 2 | 13 | |
| Phase 2/3 | 1 | |
| Phase 3 | 5 | |
| Phase 4 | 7 |
| NCT ID | Title | Condition | Status | Updated |
|---|---|---|---|---|
| Phase 4 | ||||
| NCT03438526 | The Basel BOMP-AID Randomized Trial | Hypoactive Delirium | Recruiting | 2026-06-11 |
| NCT04555785 | Enhancement of the Haemostatic Effect of Platelets in the Presence of High Normal… | Bleeding | Recruiting | 2026-06-11 |
| NCT03153527 | Taper Or Abrupt Steroid Stop: TOASSTtrial | Inflammatory Disorder | Recruiting | 2026-04-22 |
| NCT07045935 | Metabolic Outcomes in Patients With Prolactinomas Under Dopamine Agonist Treatment | Prolactinoma | Recruiting | 2025-09-23 |
| NCT04095572 | Alternative Prophylaxis in Female Recurrent Urinary Tract Infections | Urinary Tract Infections | Recruiting | 2025-02-19 |
| NCT06408688 | Safety and Modulation of Adaptive Immunity by Iscador® Qu Viscum Album Extract in… | Advanced Solid Tumor | Recruiting | 2024-12-27 |
| NCT07428681 | Lorazepam for Delirium Prevention in Critically Ill Patients With High Anttila-Index | Delirium Confusional State | Not Yet Recruiting | 2026-02-27 |
| Phase 3 | ||||
| NCT06936774 | Improving Functional Outcomes and Quality of Life in Patients With Rectal Cancer After… | LARS - Low Anterior Resection Syndrome | Recruiting | 2026-05-06 |
| NCT05890664 | Colchicine After Electrocardioversion for Atrial Fibrillation | Atrial Fibrillation | Recruiting | 2025-05-28 |
| NCT05401578 | Canakinumab for the Treatment of Postprandial Hypoglycemia | Postprandial Hypoglycemia | Recruiting | 2025-01-29 |
| NCT07682558 | Efficacy of Non-opioid Drugs in Addition to Opioid Therapy for Cancer Pain Management | Cancer Pain | Not Yet Recruiting | 2026-08-19 |
| NCT03735901 | Enhancement of Stroke Rehabilitation With Levodopa | Acute Stroke | Active, Not Recruiting | 2024-10-15 |
| Phase 2/3 | ||||
| NCT07302919 | Transarterial Chemoembolization (TACE) Plus ABCB1 Inhibition Versus TACE Alone in… | Hepato Cellular Carcinoma (HCC) | Recruiting | 2026-03-02 |
| Phase 2 | ||||
| NCT06163573 | Treatment of Patellofemoral Osteoarthritis With Engineered Cartilage. | Patellofemoral Osteoarthritis | Recruiting | 2026-09-10 |
| NCT07368153 | Safety and Tolerability of IDO-1 Inhibition in the Prevention of EBV-related Pathology in… | EBV Infections | Recruiting | 2026-08-25 |
| NCT06036004 | Oxytocin Substitution Therapy in Patients With Central Diabetes Insipidus | Central Diabetes Insipidus (cDI) | Recruiting | 2026-05-06 |
| NCT05883540 | Lysergic Acid Diethylamide (LSD) in Palliative Care | Palliative Care | Recruiting | 2026-04-29 |
| NCT06576583 | Implantation of Engineered Cartilage Grafts for Treatment of Patellofemoral… | Patellofemoral Osteoarthritis | Recruiting | 2026-03-24 |
| NCT03805477 | Nintedanib in Patients With Bronchiolitis Obliterans Syndrome Following Hematopoietic… | Bronchiolitis Obliterans Syndrome (BOS) | Recruiting | 2025-12-15 |
| NCT06455917 | TIL Therapy in Non-small-cell Lung Cancer (NSCLC) Patients | Non-Small Cell Lung Cancer | Recruiting | 2025-11-19 |
| NCT06808516 | Effects of Intranasal Oxytocin on Sexual Well-Being in Patients With Arginine Vasopressin… | Arginine Vasopressin Deficiency | Recruiting | 2025-10-03 |
| NCT06676774 | Effect of Intranasal Oxytocin on Emotion Recognition and Acute Psycho-Social… | Arginine Vasopressin Deficiency | Recruiting | 2025-05-23 |
| NCT02007356 | A Study to Assess Safety and Feasibility of Direct Infusions of Donor-derived… | Adenovirus Infection | Recruiting | 2025-03-20 |
| NCT03781128 | Lysergic Acid Diethylamide (LSD) as Treatment for Cluster Headache | Cluster Headache | Recruiting | 2025-02-07 |
| NCT05655091 | Target Attainment of Continuous Infusion Flucloxacillin and Cefazolin Coupled With TDM… | Complicated Staphylococcus Aureus (S. Aureus) Infections (CSAI) | Recruiting | 2024-12-16 |
Heart Disease (26) · Stroke (9) · Breast Cancer (8) · Atrial Fibrillation (7) · Multiple Sclerosis (6) · Heart Failure (5) · Obesity (5) · Coronary Artery Disease (4) · Hypertension (4) · Diabetes (3)